SHAREHOLDER ALERT: Morris Kandinov Investigating LDI, CCL, CORT, and MIDQX; Shareholders are Encouraged to Contact the Firm
September 30 2021 - 7:00AM
National law firm Morris Kandinov is investigating the actions of
the officers and board of directors of loanDepot, Inc., Carnival
Corporation and plc, Corcept Therapeutics, Inc., and DWS ESG Core
Equity Fund. If you are a current owner of shares of
any of these stocks, contact leo@moka.law or call (619) 708-3993.
loanDepot, Inc.
(NYSE: LDI) Accused of
Misleading Investors
Morris Kandinov announces that a class action
lawsuit has been filed against loanDepot, Inc. and certain of its
officers. The class action is on behalf of persons who purchased
loanDepot stock pursuant or traceable to the company's Registration
Statement and Prospectus issued in connection with the
company's February 16, 2021 initial public offering.
By August 17, 2021, loanDepot's stock fell
to $8.07 per share, a more than 42% decline from the IPO
price of $14 per share, having plummeted in response to
information reflecting the materialization of significant risks
misrepresented and omitted from the offering documents. If you are
a shareholder who purchased loanDepot securities pursuant to the
IPO, you have until November 8, 2021 to ask the court to
appoint you as Lead Plaintiff for the class. To learn more about
this investigation and your rights,
visit: https://moka.law/case-contact-form/. Representation is
contingency based, no out of pocket costs.
Carnival Corporation & plc (NYSE:
CCL) Shareholder Rights Investigation
Morris Kandinov is investigating Carnival
Corporation and plc regarding corporate governance failures,
possible breaches of fiduciary duties and other violations of
law. As alleged in the pending securities class action
complaint, defendants made materially false, and/or misleading
statements, and failed to disclose material adverse facts about
Carnival’s inability to address the spread of infectious disease on
its ships (including COVID-19) and the susceptibility of its ships
to the transmission of such diseases among its crew and passengers.
As a result of the foregoing, defendants’ statements about
Carnival’s commitment to the health, safety, and comfort of its
passengers and crew members as well as its assurances to
safeguarding passengers and crew and, thereby its profitability,
were false and/or misleading and/or lacked a reasonable basis. As a
result of the revelation of the truth about Carnival’s inability
and unwillingness to deal with the spread of infectious diseases on
its ships, Carnival investors who purchased Carnival securities on
U.S. exchanges lost billions of dollars when Carnival’s shares
declined following Carnival’s corrective revelations. To learn more
about this investigation and your rights,
visit: https://moka.law/case-contact-form/. Representation is
contingency based, no out of pocket costs.
Corcept Therapeutics, Inc.
(NASDAQ: CORT) Accused
of Misleading Investors
On August 24, 2021, Judge Lucy Koh of the United
States District Court for the Northern District of California
issued an order denying in part the defendants’ motion to dismiss
in the pending securities class action against Corcept
Therapeutics, Inc., paving the way for litigation to proceed.
Corcept is a pharmaceutical company that develops medications to
treat severe metabolic, oncologic, and psychiatric disorders. On
March 14, 2019, a lawsuit was filed against Corcept over alleged
securities laws violations. The plaintiff alleged that Corcept had
improperly paid doctors to promote its drug Korlym, that the
company aggressively promoted Korlym for off-label uses, that the
company’s sole specialty pharmacy was a related party, that the
company artificially inflated its revenue and sales using illicit
sales practices through a related party, and that such practices
are reasonably likely to lead to regulatory scrutiny. Morris
Kandinov is investigating Corcept regarding possible breaches of
fiduciary duties and other violations of law, on behalf of
shareholders. To learn more about this investigation and your
rights, visit: https://moka.law/case-contact-form/.
Representation is contingency based, no out of pocket costs.
DWS ESG Core Equity Fund - Class R
(NASDAQ: MIDQX)
Shareholder Rights Investigation
Morris Kandinov is investigating DWS ESG Core
Equity Fund regarding possible breaches of fiduciary duties and
other violations of law, including securities claims on behalf of
shareholders. To learn more about this investigation and your
rights, visit: https://moka.law/case-contact-form/.
Representation is contingency based, no out of pocket costs.
Concerned shareholders are encouraged to contact
Leo Kandinov to learn more:
leo@moka.law (619) 708-3993moka.law
Morris Kandinov LLP is a national law firm that
specializes in recovering investment losses and protecting
stockholder rights. We work on contingency (i.e., you do not pay
our fees out-of-pocket), and our attorneys have made substantial
recoveries for investors in jurisdictions across the
country. The firm would be happy to further discuss
these matters, and any legal rights or remedies potentially
available to you, at no charge.
Attorney Advertising. Past results do not
guarantee a similar outcome.
Contact:
Leo Kandinov, Partnerleo@moka.law619-708-3993550
West B Street, 4th FloorSan Diego, CA 92101moka.law
Carnival (NYSE:CCL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Carnival (NYSE:CCL)
Historical Stock Chart
From Sep 2023 to Sep 2024